Top news
Novo Nordisk plummets 18% on stock market after report signals weaker 2026 outlook
Novo Nordisk is plummeting in early trading on the Copenhagen Stock Exchange. The release of yesterday's report points to continued difficulties for the Danish pharmaceutical giant.
Business


